A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide aloneJulie N. Graff, Amy E. Moran|Journal for ImmunoTherapy of Cancer|2020Cited by 120
Gonadotropin-Releasing Hormone Antagonists in Prostate Cancer.Adam S. Kittai, Julie N. Graff, Jessica A. Blank|PubMed|2018Cited by 23
Prolonged Response to an IGF-1 Receptor Antibody in a Patient with Metastatic Castration Prostate Cancer with Neuroendocrine DifferentiationJulie N. Graff, Tomasz M. Beer|Cureus|2015Cited by 5